Concepedia

Eugene Schneider

ES

Statistics

Publications

28

Citations

6.5K

H-Index

21

Active since

2006

Affiliations

Ionis Pharmaceuticals (United States)(Current)

Stanford University

Biogen (United States)

Columbia University Irving Medical Center

University of California San Diego

Eugene Schneider is an author at Ionis Pharmaceuticals (United States) specializing in medicine, neurology, and pharmacology.

Publications per year

2006–2025

28

Publications

28

Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy

Richard S. Finkel, Eugenio Mercuri, Basil T. Darras et al. · New England Journal of Medicine · 2017 · 2.3K citations · Full text

, , +17

Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy

Eugenio Mercuri, Basil T. Darras, Claudia A. Chiriboga et al. · New England Journal of Medicine · 2018 · 1.4K citations · Full text

, , +17

Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study

Richard S. Finkel, Claudia A. Chiriboga, Jiri Vajsar et al. · The Lancet · 2016 · 1K citations

, , +9

Nusinersen in later-onset spinal muscular atrophy

Basil T. Darras, Claudia A. Chiriboga, Susan T. Iannaccone et al. · Neurology · 2019 · 260 citations · Full text

, , +13

Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment

Jeffrey L. Cummings, Eugene Schneider, Pierre N. Tariot et al. · Neurology · 2006 · 223 citations

, , +17

1–5 of 28